Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones
The characterization of circulating tumor cells (CTCs) holds promises for precision medicine because these cells are an important clinical indicator of treatment efficacy. We established the first and still only nine permanent colon CTC lines from peripheral blood samples of a patient with metastati...
Saved in:
Published in | Molecular cancer Vol. 20; no. 1; pp. 30 - 6 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
08.02.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!